India to Turkey: Atovaquone Export Trade Route

The India to Turkey Atovaquone corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $172.4K USD. The route is dominated by YASHICA PHARMACEUTICALS PRIVATE LIMITED , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's atovaquone manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $86.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with atovaquone's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 31.5%, placing it at rank #4 among India's top atovaquone export destinations globally.

On the import side, key buyers of Indian atovaquone in Turkey include TO THE ORDER . TO THE ORDER is the single largest importer with 2 shipments valued at $172.4K USD.

India's atovaquone exports to Turkey are driven primarily by a handful of large-scale manufacturers. YASHICA PHARMACEUTICALS PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — YASHICA PHARMACEUTICALS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $86.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, TO THE ORDER is the largest importer with 2 shipments worth $172.4K USD — representing 100% of all atovaquone imports from India on this route.